Fertility News and Research RSS Feed - Fertility News and Research

Prenatal exposure to phthalate DiNP associated with shorter AGD in Swedish boys: Study

Prenatal exposure to phthalate DiNP associated with shorter AGD in Swedish boys: Study

The first study to examine prenatal exposure to the phthalate DiNP finds it is associated with a shorter anogenital distance (AGD) in Swedish boys at the age of 21 months. These findings raise concern since animal research has linked DiNP exposure to a shorter AGD, and studies on humans have related shorter AGD to male genital birth defects as well as impaired reproductive function in adult males, and the levels of DiNP metabolites in humans are increasing globally. [More]
Study sheds light on the mystery of biological clock that controls fertility in women

Study sheds light on the mystery of biological clock that controls fertility in women

Researchers at the University of Gothenburg have identified the biological clock that governs female fertility. The discovery represents a major contribution to research aimed at finding medical approaches to treating infertility in women. [More]
UMass Amherst epidemiologist investigates risk of early menopause

UMass Amherst epidemiologist investigates risk of early menopause

The estimated 10 percent of women in Western nations who enter menopause before age 45 have an elevated risk of cardiovascular disease, as well as lower fertility. Now epidemiologist Elizabeth Bertone-Johnson at the University of Massachusetts Amherst is conducting the first large study to investigate whether vitamin D deficiency, inflammatory factors, hormones and other factors are associated with risk of early menopause, funded by NIH. [More]
New research suggests that exposure to aluminium may reduce male fertility

New research suggests that exposure to aluminium may reduce male fertility

And the team of scientists, at the universities of Lyon and Saint-Etienne in France and Keele in the UK, found that the higher the aluminium, the lower sperm count. [More]
Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company, has announced the launch of its lead product Rasuvo (methotrexate) injection for patients with rheumatoid arthritis (RA), poly-articular-course juvenile idiopathic arthritis (pJIA) and psoriasis in the U.S. [More]
Silicon Valley using health care perks to lure talent

Silicon Valley using health care perks to lure talent

High salaries and free food aren't enough any more in Silicon Valley, where maturing companies are competing for talent with creative health care and "wellness" programs that use gadgets to promote good behavior. Standard benefits at the largest technology companies, including Google Inc and Apple Inc, range from fertility treatments to deluxe on-site medical clinics, to new technology treats like health-tracking bracelets. The health largesse separates Silicon Valley's raging economy from many other sectors in the United States, but tech companies' experiments with perks show signs of spreading, benefits managers say. [More]
Chemotherapy, radiotherapy have no negative effect on unborn babies

Chemotherapy, radiotherapy have no negative effect on unborn babies

Children who are exposed to chemotherapy or radiotherapy while in the womb suffer no negative impacts on mental or cardiac development, international studies presented at the ESMO 2014 Congress in Madrid have shown. [More]
EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million. [More]
New NIH program awards $2.5 million to spur innovation in mobile health

New NIH program awards $2.5 million to spur innovation in mobile health

A new NIH program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs). [More]
Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

Unisense FertiliTech's EmbryoViewer software gets FDA approval for IVF practices

World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare & Select" feature in the EmbryoViewer software - an accessory to the EmbryoScope time-lapse incubator - which assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals wishing to become a parent. [More]
Study addresses challenge of developing effective strategies to prevent gender-based violence

Study addresses challenge of developing effective strategies to prevent gender-based violence

Gender-based violence affects the physical and mental health of girls and boys, men and women worldwide. A recent study by researchers from the Institute for Reproductive Health at Georgetown University addresses the challenge of developing effective strategies to change inequitable and harmful social norms that result in gender-based violence. [More]
High impact health interventions reduce maternal and child mortality in poor countries

High impact health interventions reduce maternal and child mortality in poor countries

New studies have uncovered the specific interventions and advances that have led to the success with these at-risk populations in the poorest countries. [More]
Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. [More]
Researchers hope to find new ways to combat age-related diseases

Researchers hope to find new ways to combat age-related diseases

Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet. [More]
Extraordinary Conceptions hosts free upcoming educational reception in Europe

Extraordinary Conceptions hosts free upcoming educational reception in Europe

Extraordinary Conceptions, a leading international egg donor and surrogacy agency based in San Diego County, will be hosting its free upcoming educational reception in Europe. [More]
Canada funds 22 inventive ideas for improving health in low-resource countries

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries. [More]
Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

Around 9.6% of women diagnosed with dry eye disease, treated with artificial tear eye drops

The symptoms of dry eye disease include the sensation of grit in the eye, frequently accompanied by itching, burning and visual disturbance. The causes are poorly understood. [More]
Research reveals that unplanned births out-of-hospital linked with higher infant mortality

Research reveals that unplanned births out-of-hospital linked with higher infant mortality

New research reveals that unplanned births out-of-hospital in Norway are associated with higher infant mortality. [More]

Facial masculinity negatively associated with semen quality

Contrary to what one might expect, facial masculinity was negatively associated with semen quality in a recent Journal of Evolutionary Biology study. [More]
Standard Days Method: A highly effective fertility awareness-based family planning method

Standard Days Method: A highly effective fertility awareness-based family planning method

There is no guarantee that a successful pilot program introducing a health innovation can be expanded successfully to the national, regional, state or even metropolitan level because scaling up is typically complex and difficult. [More]